Review



rabbit anti mouse bfgf monoclonal antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss rabbit anti mouse bfgf monoclonal antibody
    Rabbit Anti Mouse Bfgf Monoclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti mouse bfgf monoclonal antibody/product/Bioss
    Average 94 stars, based on 30 article reviews
    rabbit anti mouse bfgf monoclonal antibody - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Bioss rabbit anti mouse bfgf monoclonal antibody
    Rabbit Anti Mouse Bfgf Monoclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti mouse bfgf monoclonal antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit anti mouse bfgf monoclonal antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc antibodies rabbit monoclonal anti bfgf
    The bFGFmAb and its characteristics. (a) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified bFGFmAb (H, heavy chain; L, light chain). (b) Concentration of the purified bFGFmAb stock solution determined by bicinchoninic acid (BCA) standard assays. (c) Titer of the purified bFGFmAb stock solution tested by indirect ELISA. (d) The bFGFmAb inhibits the proliferation of A549 and A549/DDP cells. (e) Treatment with <t>bFGF</t> increases the proliferation in A549 and A549/DDP cells. bFGF, basic fibroblast growth factor; DDP, cisplatin; ELISA, enzyme-linked immunosorbent assay; mAb, <t>monoclonal</t> antibody; OD, optical density.
    Antibodies Rabbit Monoclonal Anti Bfgf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies rabbit monoclonal anti bfgf/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    antibodies rabbit monoclonal anti bfgf - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti rabbit monoclonal bfgf antibody
    The expression of <t>rc-bFGF</t> mRNA in the purification process of rc-bFGF by the cell-free protein synthesis system. Lane 1–6: the results of RT-PCR in reaction solution after synthesis of canine bFGF. Lane 7-12: the results of RT-PCR in reaction solution without synthesis of canine bFGF (negative control). Lane 13–18: the results of PCR in the pET28a plasmid for synthesis by E. coli (positive control).
    Anti Rabbit Monoclonal Bfgf Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rabbit monoclonal bfgf antibody/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    anti rabbit monoclonal bfgf antibody - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit monoclonal anti bfgf
    The expression of <t>rc-bFGF</t> mRNA in the purification process of rc-bFGF by the cell-free protein synthesis system. Lane 1–6: the results of RT-PCR in reaction solution after synthesis of canine bFGF. Lane 7-12: the results of RT-PCR in reaction solution without synthesis of canine bFGF (negative control). Lane 13–18: the results of PCR in the pET28a plasmid for synthesis by E. coli (positive control).
    Rabbit Monoclonal Anti Bfgf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti bfgf/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    rabbit monoclonal anti bfgf - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    90
    Millipore monoclonal mouse anti-rabbit bfgf
    The expression of <t>rc-bFGF</t> mRNA in the purification process of rc-bFGF by the cell-free protein synthesis system. Lane 1–6: the results of RT-PCR in reaction solution after synthesis of canine bFGF. Lane 7-12: the results of RT-PCR in reaction solution without synthesis of canine bFGF (negative control). Lane 13–18: the results of PCR in the pET28a plasmid for synthesis by E. coli (positive control).
    Monoclonal Mouse Anti Rabbit Bfgf, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal mouse anti-rabbit bfgf/product/Millipore
    Average 90 stars, based on 1 article reviews
    monoclonal mouse anti-rabbit bfgf - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    The bFGFmAb and its characteristics. (a) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified bFGFmAb (H, heavy chain; L, light chain). (b) Concentration of the purified bFGFmAb stock solution determined by bicinchoninic acid (BCA) standard assays. (c) Titer of the purified bFGFmAb stock solution tested by indirect ELISA. (d) The bFGFmAb inhibits the proliferation of A549 and A549/DDP cells. (e) Treatment with bFGF increases the proliferation in A549 and A549/DDP cells. bFGF, basic fibroblast growth factor; DDP, cisplatin; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; OD, optical density.

    Journal: International Journal of Immunopathology and Pharmacology

    Article Title: A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition

    doi: 10.1177/03946320221105134

    Figure Lengend Snippet: The bFGFmAb and its characteristics. (a) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified bFGFmAb (H, heavy chain; L, light chain). (b) Concentration of the purified bFGFmAb stock solution determined by bicinchoninic acid (BCA) standard assays. (c) Titer of the purified bFGFmAb stock solution tested by indirect ELISA. (d) The bFGFmAb inhibits the proliferation of A549 and A549/DDP cells. (e) Treatment with bFGF increases the proliferation in A549 and A549/DDP cells. bFGF, basic fibroblast growth factor; DDP, cisplatin; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; OD, optical density.

    Article Snippet: After blocking with 5% blotto (skimmed milk) in Tris-buffered saline and Tween 20 for 1 h, the primary antibodies rabbit monoclonal anti-bFGF (CST, USA; 1:1000 dilution), mouse monoclonal anti-E-cadherin (CST, 1:1000 dilution), rabbit polyclonal anti-N-cadherin (Abcam, UK; 1:1000 dilution), rabbit polyclonal anti-LRP (Santa Cruz, USA, 1:200 dilution), and mouse monoclonal anti-β-actin (CST, USA, 1:1000 dilution) were added and incubated at 4°C overnight.

    Techniques: Polyacrylamide Gel Electrophoresis, Purification, Concentration Assay, Indirect ELISA, Enzyme-linked Immunosorbent Assay

    Effects of  bFGF  and bFGFmAb on cisplatin resistance in non-small cell lung cancer.

    Journal: International Journal of Immunopathology and Pharmacology

    Article Title: A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition

    doi: 10.1177/03946320221105134

    Figure Lengend Snippet: Effects of bFGF and bFGFmAb on cisplatin resistance in non-small cell lung cancer.

    Article Snippet: After blocking with 5% blotto (skimmed milk) in Tris-buffered saline and Tween 20 for 1 h, the primary antibodies rabbit monoclonal anti-bFGF (CST, USA; 1:1000 dilution), mouse monoclonal anti-E-cadherin (CST, 1:1000 dilution), rabbit polyclonal anti-N-cadherin (Abcam, UK; 1:1000 dilution), rabbit polyclonal anti-LRP (Santa Cruz, USA, 1:200 dilution), and mouse monoclonal anti-β-actin (CST, USA, 1:1000 dilution) were added and incubated at 4°C overnight.

    Techniques:

    Effects of the bFGFmAb on the morphology of non-small cell lung cancer cells. EMT cell morphology is evident in both A549 and A549/DDP cells after treatment with bFGF. A549 cells become a long fusiform and spindle shaped phenotype, while A549/DDP cells transform to a long, thin and more irregular shape. Treatment of the cells with bFGFmAb attenuates/reverses the bFGF-induced EMT transformation. bFGF, basic fibroblast growth factor; DDP, cisplatin; EMT, epithelial-to-mesenchymal transition; mAb, monoclonal antibody.

    Journal: International Journal of Immunopathology and Pharmacology

    Article Title: A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition

    doi: 10.1177/03946320221105134

    Figure Lengend Snippet: Effects of the bFGFmAb on the morphology of non-small cell lung cancer cells. EMT cell morphology is evident in both A549 and A549/DDP cells after treatment with bFGF. A549 cells become a long fusiform and spindle shaped phenotype, while A549/DDP cells transform to a long, thin and more irregular shape. Treatment of the cells with bFGFmAb attenuates/reverses the bFGF-induced EMT transformation. bFGF, basic fibroblast growth factor; DDP, cisplatin; EMT, epithelial-to-mesenchymal transition; mAb, monoclonal antibody.

    Article Snippet: After blocking with 5% blotto (skimmed milk) in Tris-buffered saline and Tween 20 for 1 h, the primary antibodies rabbit monoclonal anti-bFGF (CST, USA; 1:1000 dilution), mouse monoclonal anti-E-cadherin (CST, 1:1000 dilution), rabbit polyclonal anti-N-cadherin (Abcam, UK; 1:1000 dilution), rabbit polyclonal anti-LRP (Santa Cruz, USA, 1:200 dilution), and mouse monoclonal anti-β-actin (CST, USA, 1:1000 dilution) were added and incubated at 4°C overnight.

    Techniques: Transformation Assay

    The bFGFmAb regulates markers for EMT and suppresses LRP expression. Treatment with bFGFmAb leads a significantly decrease in expression of bFGF, N-cadherin, and LRP, and a significantly increases in the expression of E-cadherin in both A549 and A549/DDP cells. N-cadherin and E-cadherin are EMT markers. * p < 0.05. bFGF, basic fibroblast growth factor; DDP, cisplatin; EMT, epithelial-to-mesenchymal transition; LRP, lung resistance protein; mAb, monoclonal antibody.

    Journal: International Journal of Immunopathology and Pharmacology

    Article Title: A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition

    doi: 10.1177/03946320221105134

    Figure Lengend Snippet: The bFGFmAb regulates markers for EMT and suppresses LRP expression. Treatment with bFGFmAb leads a significantly decrease in expression of bFGF, N-cadherin, and LRP, and a significantly increases in the expression of E-cadherin in both A549 and A549/DDP cells. N-cadherin and E-cadherin are EMT markers. * p < 0.05. bFGF, basic fibroblast growth factor; DDP, cisplatin; EMT, epithelial-to-mesenchymal transition; LRP, lung resistance protein; mAb, monoclonal antibody.

    Article Snippet: After blocking with 5% blotto (skimmed milk) in Tris-buffered saline and Tween 20 for 1 h, the primary antibodies rabbit monoclonal anti-bFGF (CST, USA; 1:1000 dilution), mouse monoclonal anti-E-cadherin (CST, 1:1000 dilution), rabbit polyclonal anti-N-cadherin (Abcam, UK; 1:1000 dilution), rabbit polyclonal anti-LRP (Santa Cruz, USA, 1:200 dilution), and mouse monoclonal anti-β-actin (CST, USA, 1:1000 dilution) were added and incubated at 4°C overnight.

    Techniques: Expressing

    The expression of rc-bFGF mRNA in the purification process of rc-bFGF by the cell-free protein synthesis system. Lane 1–6: the results of RT-PCR in reaction solution after synthesis of canine bFGF. Lane 7-12: the results of RT-PCR in reaction solution without synthesis of canine bFGF (negative control). Lane 13–18: the results of PCR in the pET28a plasmid for synthesis by E. coli (positive control).

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: The expression of rc-bFGF mRNA in the purification process of rc-bFGF by the cell-free protein synthesis system. Lane 1–6: the results of RT-PCR in reaction solution after synthesis of canine bFGF. Lane 7-12: the results of RT-PCR in reaction solution without synthesis of canine bFGF (negative control). Lane 13–18: the results of PCR in the pET28a plasmid for synthesis by E. coli (positive control).

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Expressing, Purification, Reverse Transcription Polymerase Chain Reaction, Negative Control, Plasmid Preparation, Positive Control

    Western blotting of purified protein. Band formation was observed at almost same position as rc-bFGF synthesized using E. coli (arrows). Lane 1: reaction solution after synthesis of canine bFGF. Lane 2: reaction solution without synthesis of canine bFGF (negative control). Lane 3: rc-bFGF synthesized using E. coli, Lane 4: commercially available rh-bFGF (positive control).

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: Western blotting of purified protein. Band formation was observed at almost same position as rc-bFGF synthesized using E. coli (arrows). Lane 1: reaction solution after synthesis of canine bFGF. Lane 2: reaction solution without synthesis of canine bFGF (negative control). Lane 3: rc-bFGF synthesized using E. coli, Lane 4: commercially available rh-bFGF (positive control).

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Western Blot, Purification, Synthesized, Negative Control, Positive Control

    Phosphorylation of ERK in HEK293 cells after stimulation by purified protein. pERK expression was observed after stimulation of HEK293 cells by our purified protein, as it was after stimulation by commercially available rh-bFGF. Lane 1: extract from HEK293 cells after no stimulation of rc-bFGF or rh-bFGF (negative control). Lane 2: extract from HEK293 cells after stimulation by 5 ng/mL of rc-bFGF. Lane 3: extract from HEK293 cells after stimulation by 15 ng/mL of rc-bFGF. Lane 4: rc-bFGF synthesized solution only. Lane 5: extract from HEK293 cells after stimulation by 5 ng/mL of commercially available rh-bFGF (positive control). Lane 6: blotting buffer.

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: Phosphorylation of ERK in HEK293 cells after stimulation by purified protein. pERK expression was observed after stimulation of HEK293 cells by our purified protein, as it was after stimulation by commercially available rh-bFGF. Lane 1: extract from HEK293 cells after no stimulation of rc-bFGF or rh-bFGF (negative control). Lane 2: extract from HEK293 cells after stimulation by 5 ng/mL of rc-bFGF. Lane 3: extract from HEK293 cells after stimulation by 15 ng/mL of rc-bFGF. Lane 4: rc-bFGF synthesized solution only. Lane 5: extract from HEK293 cells after stimulation by 5 ng/mL of commercially available rh-bFGF (positive control). Lane 6: blotting buffer.

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Phospho-proteomics, Purification, Expressing, Negative Control, Synthesized, Positive Control

    The morphologies of canine BMSCs at 10 days of neuronal induction. Canine BMSCs were changed to a neuron-like morphology after neuronal induction in the rh-bFGF and the rc-bFGF groups (arrows). A: control group, B: undifferentiated group, C: rh-bFGF group, and D: rc-bFGF group.

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: The morphologies of canine BMSCs at 10 days of neuronal induction. Canine BMSCs were changed to a neuron-like morphology after neuronal induction in the rh-bFGF and the rc-bFGF groups (arrows). A: control group, B: undifferentiated group, C: rh-bFGF group, and D: rc-bFGF group.

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Control

    The percentage of canine BMSCs that had changed to a neuron-like morphology at 10 days of neuronal induction. Error bars show mean ± standard error (n = 6 in each group). Asterisks indicate statistical difference among the groups ( P < 0.05). Control; control group, Undifferent; undifferentiated group, rh-bFGF; rh-bFGF group, rc-bFGF; rc-bFGF group.

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: The percentage of canine BMSCs that had changed to a neuron-like morphology at 10 days of neuronal induction. Error bars show mean ± standard error (n = 6 in each group). Asterisks indicate statistical difference among the groups ( P < 0.05). Control; control group, Undifferent; undifferentiated group, rh-bFGF; rh-bFGF group, rc-bFGF; rc-bFGF group.

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Control

    The mRNA expression of neuronal markers pre- and post-neuronal induction. A: NEFL , B: NEFH , C: MAP2 , and D: TUBB3 . Error bars show mean ± standard error (n = 6 in each group). Asterisks indicate statistical difference between pre- and post-neuronal induction ( P < 0.05). Control; control group, Undifferent; undifferentiated group, rh-bFGF; rh-bFGF group, rc-bFGF; rc-bFGF group.

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: The mRNA expression of neuronal markers pre- and post-neuronal induction. A: NEFL , B: NEFH , C: MAP2 , and D: TUBB3 . Error bars show mean ± standard error (n = 6 in each group). Asterisks indicate statistical difference between pre- and post-neuronal induction ( P < 0.05). Control; control group, Undifferent; undifferentiated group, rh-bFGF; rh-bFGF group, rc-bFGF; rc-bFGF group.

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Expressing, Control

    Relative fluorescence intensity of intracellular Ca 2+ concentration after the stimulation by 50 mM KCl (A, B, C, D) or 100 μ M l -glutamate (E, F, G, H). A and E: Control group, B and F: Undifferentiated group, C and G: rh-bFGF group, D and H: rc-bFGF group.

    Journal: Regenerative Therapy

    Article Title: Recombinant canine basic fibroblast growth factor-induced differentiation of canine bone marrow mesenchymal stem cells into voltage- and glutamate-responsive neuron-like cells

    doi: 10.1016/j.reth.2020.07.005

    Figure Lengend Snippet: Relative fluorescence intensity of intracellular Ca 2+ concentration after the stimulation by 50 mM KCl (A, B, C, D) or 100 μ M l -glutamate (E, F, G, H). A and E: Control group, B and F: Undifferentiated group, C and G: rh-bFGF group, D and H: rc-bFGF group.

    Article Snippet: The membranes were incubated with the anti-rabbit monoclonal bFGF antibody (Cell Signaling Technology Inc., Danvers, MA, U.S.A.).

    Techniques: Fluorescence, Concentration Assay, Control